The Journal of Bone and Joint Surgery 82:1140 (2000)
© 2000 The Journal of Bone and Joint Surgery, Inc.
Chondroblastoma of Bone*
Arun J. Ramappa, M.D. ,
Francis Y. I. Lee, M.D. ,
Peter Tang, M.D.§,
Jeffrey R. Carlson, M.D.#,
Mark C. Gebhardt, M.D. and
Henry J. Mankin, M.D.
Investigation performed at the Orthopaedic Oncology Service,
Massachusetts General Hospital,
and Children's Hospital, Harvard Medical School, Boston, Massachusetts
*No benefits in any form have been received or will be received
from a commercial party related directly or indirectly to the subject
of this article. No funds were received in support of this study.
Orthopaedic Service, Gray 604, Massachusetts General Hospital,
Boston, Massachusetts 02114. E-mail address for H. J. Mankin: hmankin{at}partners.org
Department of Orthopaedics, Columbia University School of Medicine,
622 West 168th Street, New York, N.Y. 10032.
§Orthopaedic Service, University of Pittsburgh, Kaufmann Building,
3471 Fifth Avenue, Pittsburgh, Pennsylvania 15213.
#751 J. Clyde Morris Boulevard, Newport News, Virginia 23601.
Background: Chondroblastoma of bone is a
rare lesion, and few large series have been reported. The purpose
of this paper is to report forty-seven cases treated by one group
of surgeons and to identify factors associated with more aggressive
tumor behavior.
Methods: Seventy-three patients with chondroblastoma
of bone were treated between 1977 and 1998. We were able to obtain
historical data, imaging studies, histological findings, and adequate
personal or telephone follow-up to determine the outcome for forty-seven
patients.
Results: The lesions were distributed widely
in the skeleton, but most were in the epiphyses or apophyses of
the long bones, especially the proximal part of the tibia (eleven
tumors) and the proximal part of the humerus (ten tumors). The principal
presenting symptoms were pain and limitation of movement. The treatment
consisted of a variety of procedures, but the majority of the patients
had intralesional curettage and packing with allograft or autograft bone
chips or polymethylmethacrylate. Most of the patients had an excellent
functional result, although in three osteoarthritis developed in
the adjacent joint. Seven patients (15 percent) had a local recurrence;
three of them had a second recurrence and one, a third recurrence.
One patient died of widespread metastases, and another who had metastases
to multiple sites was alive and disease-free after aggressive treatment
of the metastatic lesions.
Conclusions: While the size of the lesion, the
age and gender of the patient, the status of the growth plate, and
an aneurysmal-bone-cyst component to the tumor had no significant
effect on the recurrence rate, lesions around the hip (the proximal
part of the femur, the greater trochanter, and the pelvis) accounted
for the majority (five) of the seven recurrent tumors and one of
the two metastatic lesions.

CiteULike Connotea Del.icio.us Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Maezawa, M. Nozawa, T. Takagi, D. Imai, K. Shitoto, and H. Kurosawa
Rotational Acetabular Osteotomy for Benign Chondroblastoma of the Femoral Head. A Case Report
J. Bone Joint Surg. Am.,
June 1, 2005;
87(6):
1358 - 1362.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Erickson, D. I. Rosenthal, D. J. Zaleske, M. C. Gebhardt, and J. M. Cates
Primary Treatment of Chondroblastoma with Percutaneous Radio-frequency Heat Ablation: Report of Three Cases
Radiology,
November 1, 2001;
221(2):
463 - 468.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|